drugset / Trial / NCT06624592

Sevoflurane/Dexmedetomidine vs. Isoflurane for Pediatric Emergence Delirium

NCT06624592

Phase 3 Recruiting 400 enrolled Mayo Clinic
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to measure the incidences of pediatric emergence delirium between the group receiving Isoflurane and the group receiving Sevoflurane plus intravenous push dexmedetomidine.

Timeline

Start
2024-12-20
Primary completion
2026-11-01
Completion
2026-11-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Isoflurane Other / unclassified
Comparator Sevoflurane Other / unclassified
Background Dexmedetomidine Other / unclassified Intravenous

Indications